Postoperative Crohn's Disease

Area of Science:

• Gastroenterology
• Surgical Gastroenterology
• Clinical Medicine

Background:

• Crohn's disease management involves surgical interventions, with bowel resection remaining a key therapeutic option despite declining rates.
• Optimizing patient status preoperatively and planning for postoperative recovery, including nutritional support and pharmacotherapy, are crucial.

Purpose of the Study:

• To outline current best practices for perioperative management and postoperative surveillance following bowel resection in Crohn's disease patients.
• To highlight the role of medical therapies, particularly biologics, in preventing disease recurrence after surgery.

Main Methods:

• Review of current clinical practices and evidence regarding perioperative optimization and postoperative management strategies.
• Discussion of diagnostic modalities for assessing disease recurrence, including ileocolonoscopy, advanced imaging, and biomarker analysis.

Main Results:

• While surgery rates for Crohn's disease are decreasing, bowel resection remains significant.
• Postoperative medical therapy, often involving biological agents like infliximab, is frequently required to prevent recurrence.
• Monitoring for recurrence is recommended within 6 months via ileocolonoscopy, supplemented by imaging and biomarkers such as fecal calprotectin.

Conclusions:

• Comprehensive perioperative optimization and tailored postoperative medical management are essential for successful outcomes after Crohn's disease bowel resection.
• Regular endoscopic surveillance and biomarker monitoring are vital for early detection and management of disease recurrence.